Literature DB >> 1449534

Protective effect of trifluoperazine on the mitochondrial damage induced by Ca2+ plus prooxidants.

R S Pereira1, A P Bertocchi, A E Vercesi.   

Abstract

Isolated rat liver mitochondria undergo extensive swelling and disruption of membrane potential when they accumulate Ca2+ in the presence of a prooxidant such as diamide or t-butylhydroperoxide. The phenothiazinic drug trifluoperazine, at concentrations (15-35 microM) which do not inhibit respiration or the influx of Ca2+ into mitochondria, significantly protected mitochondria against the deleterious effects of Ca2+ plus a prooxidant. In contrast, at concentrations higher than 100 microM the drug potentiated these deleterious effects of Ca2+ and prooxidants and had a damaging effect per se on the inner mitochondrial membrane. It is proposed that the protection conferred by the drug is mediated by changes in membrane protein structure that decrease the production of protein thiol cross-linkings which occur when mitochondria accumulate calcium under oxidant stress conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449534     DOI: 10.1016/0006-2952(92)90074-s

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  The use of calcium blockers to study biochemical behaviour of Saccharomyces cerevisiae cells.

Authors:  R de Souza Pereira
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

Review 2.  Specific effects of reactive thiol drugs on mitochondrial bioenergetics.

Authors:  Iseli L Nantes; Tiago Rodrigues; Antonio C F Caires; Rodrigo L O R Cunha; Felipe S Pessoto; César H Yokomizo; Juliana C Araujo-Chaves; Priscila A Faria; Debora P Santana; Carolina G dos Santos
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

3.  Direct observation of oxidative stress on the cell wall of Saccharomyces cerevisiae strains with atomic force microscopy.

Authors:  R de Souza Pereira; J Geibel
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

4.  Protective effect of safranine on the mitochondrial damage induced by Fe(II)citrate: comparative study with trifluoperazine.

Authors:  R F Castilho; R S Pereira; A E Vercesi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jan-Mar       Impact factor: 2.441

Review 5.  Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis.

Authors:  Christine Konradi; Stephanie E Sillivan; Hayley B Clay
Journal:  Neurobiol Dis       Date:  2011-02-17       Impact factor: 5.996

Review 6.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.

Authors:  Hayley B Clay; Stephanie Sillivan; Christine Konradi
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

7.  Comparison of biochemical effects produced by calcium ions and by monomers of polyacrylamide (acrylamide and bisacrylamide) on strains of Saccharomyces cerevisiae used for production of chiral synthons.

Authors:  R de Souza Pereira
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

8.  Investigations of the inhibitory effect of propranolol, chlorpromazine, quinine, and dicyclohexylcarbodiimide on the swelling of yeast mitochondria in potassium acetate. Evidences for indirect effects mediated by the lipid phase.

Authors:  X Roucou; S Manon; M Guérin
Journal:  J Bioenerg Biomembr       Date:  1995-06       Impact factor: 2.945

9.  Oxidative damage to sarcoplasmic reticulum Ca(2+)-pump induced by Fe2+/H2O2/ascorbate is not mediated by lipid peroxidation or thiol oxidation and leads to protein fragmentation.

Authors:  R F Castilho; P C Carvalho-Alves; A E Vercesi; S T Ferreira
Journal:  Mol Cell Biochem       Date:  1996-06-21       Impact factor: 3.396

10.  Lipid peroxidation: the role of Ca2+ and protection by calcinine.

Authors:  R S Pereira
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.